Camelot Portfolios’s Eastman Chemical EMN Stock Holding History

Camelot Portfolios’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,658	Closed	-$466K	–	219
2018 Q2	$466K	Hold	4,658	–	–	0.2%	121
2018 Q1	$492K	Hold	4,658	–	–	0.23%	108
2017 Q4	$432K	Buy	4,658 +979	+27%	+$89K	0.2%	116
2017 Q3	$333K	Hold	3,679	–	–	0.16%	119
2017 Q2	$309K	Sell	3,679 -35	-0.9%	-$2.82K	0.15%	124
2017 Q1	$300K	Buy	+3,714	New	+$292K	0.15%	133

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Camelot Portfolios's EMN Position: Q3 2018 in Review

Camelot Portfolios sold out of Eastman Chemical (EMN) in Q3 2018, closing a stake of 4,658 shares — an estimated $466K sold.

Camelot Portfolios first reported a position in EMN in Q1 2017 and held it in 6 quarters. The position peaked at $492K in Q1 2018. 697 funds tracked by Wall St. Rank hold EMN as of Q3 2018.

Camelot Portfolios reported no remaining Eastman Chemical position as of Q3 2018 after selling out during the quarter.
Camelot Portfolios sold 4,658 Eastman Chemical shares in Q3 2018, an estimated $466K.
Camelot Portfolios first reported a position in Eastman Chemical in Q1 2017 and held it in 6 quarters.
Camelot Portfolios's Eastman Chemical position peaked at $492K in Q1 2018.
697 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2018.

Based on Camelot Portfolios's 13F filing for Q3 2018, filed 13 Nov 2018.